Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
Feature|Articles|March 3, 2026
2026 ACS Report Shows CRC Rising in Younger Adults Despite Overall Decline
Author(s)Brooke McCormick
Fact checked by: Julia Bonavitacola
These new data highlight CRC screening gaps, as well as disparities in incidence and survival.
Advertisement
Advertisement
Although overall
Related to this article
The pilot pairs grocery stipends and community health worker support with members who have unmanaged diabetes and unmet social needs.
Speakers at IDWeek 2026 urged shifting global health partnerships from donor-recipient models to shared, locally led ownership as funding contracts.
Insmed launches once-daily brensocatib in Japan, the country's only approved treatment for noncystic fibrosis bronchiectasis.
The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential.
ALIS added to azithromycin and ethambutol raised culture conversion in new MAC lung disease, with rare resistance, in an ENCORE analysis at IDWeek 2026.
Birth centers are unavailable in 10 states, and 39% of birth center births are self-pay, as licensing and Medicaid pay limit access, a report finds.
Cosibelimab received an NCCN Category 2A preferred designation for locally advanced CSCC, supported by durable responses and low immune toxicity.
Advertisement
Advertisement